| Value | ₹34.02 Cr |
|---|
NSE filing, NSE: SHEEL. Summary written from the filing by ALFA Finder's alert engine.
Sheel Biotech Ltd: key numbers
- Share price
- ₹61.00
- Market cap
- ₹124.2 Cr
- Revenue (annual)
- ₹110.0 Cr
- Net profit (annual)
- ₹11.76 Cr
- P/E (TTM)
- 10.6×Sector 46.8×
- Promoter holding
- 72.31%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sheel Biotech Ltd
All →Sheel Biotech Other Announcement
Sheel Biotech Limited has clarified that the Corporate Governance Report is not applicable to the company as it is listed on the SME platform.
Sheel Biotech Bags ₹4.54 Cr Order from Department of Agriculture, Government of Himachal Pradesh
Sheel Biotech won a Rs.4.54 Crore award from Himachal Pradesh's Agriculture Department. The project establishes a blueberry farm and tissue culture laboratory.
- Value
- ₹4.54 Cr
- From
- Department of Agriculture, Government of Himachal Pradesh
Sheel Biotech Legal & Regulatory
SEBI issued an advisory letter to Sheel Biotech Limited for delayed disclosure of a monitoring agency report. No monetary penalty or restrictions were imposed on the company.
Sheel Biotech Annual General Meeting
Sheel Biotech Limited held its 35th Annual General Meeting on September 24, 2026. The meeting covered adoption of financial statements and approval of other ordinary resolutions.
Sheel Biotech Other Announcement
Sheel Biotech intimated that its Statutory Auditor Shyam Sunder Mangla & Co LLP has changed its name to S S Mangla & Co LLP effective 18 December 2025. No change in the auditor appointment itself.
Sheel Biotech Bags ₹14.53 Cr Order
Sheel Biotech Limited has finalised a commercial transaction for its Blueberry project, valued at ₹14.53 Crore. This contract marks a significant business development for the company.
- Value
- ₹14.53 Cr
Other fund raise announcements
All →Om Metallogic Fund Raise
Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.
Virinchi Fund Raise of ₹30 Cr
Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.
- Value
- ₹30.00 Cr
- Execution
- Warrant tenure not exceeding 18 months from allotment
IIFL Finance Fund Raise of ₹6,414 Cr
IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.
- Value
- ₹6,414 Cr
Bajaj Finance Fund Raise of ₹5,800 Cr
Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.
- Value
- ₹5,800 Cr
Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr
Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.
- Value
- ₹5,000 Cr
- Execution
- Allotment to be completed within 365 days of shareholder approval
HB Leasing & Finance Co Fund Raise
HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.